Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers.

@article{Marrero2009ModernDO,
  title={Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers.},
  author={J. A. Fermin Marrero},
  journal={Journal of hepatology},
  year={2009},
  volume={50 4},
  pages={659-61}
}
The incidence of Hepatocellular Carcinoma (HCC) has been rising in both Europe and the United States, largely due to the growing prevalence of hepatitis C (HCV) cirrhosis [1]. Despite advances in technology and available treatments, there has been little improvement in the overall survival likely due to the fact that most patients are diagnosed at advanced stages [2,3]. Cirrhosis is the most important risk factor for the development of HCC [4]. HCV and hepatitis B (HBV) are the major… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

The application of markers (HSP 70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma

  • L Di Tommaso, A Destro, JY Seok, E Balladore, L Terracciano, A Sangiovanni
  • J Hepatol 2009;50:746–754
  • 2009
Highly Influential
3 Excerpts

Diagnostic value of HSP70, glypican-3 and glutamine synthetase in hepatocellular nodules in cirrhosis

  • L Di Tommaso, G Franchi, YN Park, B Fiamego, A Destro, E Morenghi
  • Hepatology
  • 2007
2 Excerpts

Similar Papers

Loading similar papers…